Single-use

Millipore CTDMO Services Opens Facility in France

Millipore CTDMO Services, part of the Life Science arm of Germany’s Merck, has opened a commercial facility in France.

Germany’s Merck Expands French Facility

German science and technology company Merck has announced plans to invest more than €130 million at its site in Molsheim, France, to expand capacities for single-use assemblies, a key technology for producing Covid-19 vaccines and other therapies.

News

Millipore Sigma Expands cGMP Capacity

Topics • Technology

Rentschler Expands European Manufacturing Capabilities with GE Bioprocess Technologies

News

GE Healthcare Life Sciences and Rentschler Mark Handover

Top-Feature

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

BIO Deutschland e.V.

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Expert Insights

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.